Furthermore, in OA participants with MDD, the negative correlation between BDNF levels and the HAMD-17, SDS, and VAS scores suggests that the decrease in serum levels of BDNF may reflect the severity of depression and pain. Here, BDNF is linked to depressive symptom measurement.